This suggests that the lack of S1-specific IgG detection from some recovered COVID-19 patients in our cohort is more likely due to low or absent S1-specific IgG antibody at the time of sampling, rather than a lack of sensitivity in our assay. This evidence concerns the gene PSMD1 and COVID-19.